Digital Neuro Biomarkers Market

Software-based digital biomarkers lead the digital neuro biomarkers market, followed by hospitals and neurology clinics with 38.0% share by end user and direct enterprise sales with 36.0% share by distribution channel. Adoption depends on enabling objective patient monitoring between visits, while clinical validation requirements and limited longitudinal data remain key challenges.